Prevalence of CTX-M resistance marker and integrons among Escherichia coli and Klebsiella pneumoniae isolates of clinical origin
- PMID: 26997253
- DOI: 10.1111/lam.12567
Prevalence of CTX-M resistance marker and integrons among Escherichia coli and Klebsiella pneumoniae isolates of clinical origin
Abstract
Bacterial pathogens producing CTX-M beta-lactamases are emerging around the world as a source of resistance to oxyimino cephalosporins such as cefotaxime. In this study, we have investigated the prevalence of blaCTX-M genes among clinical isolates of Escherichia coli and Klebsiella pneumoniae. Of the double-disk synergy test-positive E. coli (n = 94) and Kl. pneumoniae (n = 73) strains isolated during the study period, 41 (44·08%) E. coli and 32 (43·24%) Kl. pneumoniae isolates were found to be positive for blaCTX-M genes. Twenty-two integrons (13 for E. coli and 9 for Kl. pneumoniae) were detected whose sizes ranged from 600 bp to 1·5 kb. All these integrons were found to be of Class1 type and were invariably PCR positive for int1 and sul1 genes. Marker transfer experiments demonstrated plasmid-mediated transfer of cefotaxime and ceftazidime resistance markers. In addition, analysis of the enterobacterial repetitive intergenic consensus (ERIC)-PCR typing of the blaCTX-M -carrying isolates showed that they were genetically diverse and heterogeneous suggesting that multiple subtypes of the species were involved in infection.
Significance and impact of the study: A high frequency of blaCTX-M -resistant marker has been found in Escherichia coli and Klebsiella pneumoniae isolates of clinical origin. Analysis of the ERIC-PCR typing of the blaCTX-M -carrying isolates showed that they were genetically diverse and heterogeneous suggesting that multiple subtypes of the species were involved in infection.
Keywords: CTX-M beta-lactamases; Class 1 integrons; ERIC-PCR; Escherichia coli; Klebsiella pneumoniae; genotypic method.
© 2016 The Society for Applied Microbiology.
Similar articles
-
Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.Microb Pathog. 2017 Feb;103:8-12. doi: 10.1016/j.micpath.2016.12.004. Epub 2016 Dec 9. Microb Pathog. 2017. PMID: 27956216
-
Class 1 integrons in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Southern China during the past five years.Microb Drug Resist. 2013 Aug;19(4):289-94. doi: 10.1089/mdr.2012.0130. Epub 2013 Apr 10. Microb Drug Resist. 2013. PMID: 23573964
-
Molecular characterization of integrons in clinical isolates of betalactamase-producing Escherichia coli and Klebsiella pneumoniae in Iran.J Chemother. 2015 Jun;27(3):145-51. doi: 10.1179/1973947814Y.0000000180. Epub 2014 Feb 27. J Chemother. 2015. PMID: 24571248
-
The Spread of CTX-M-Type Extended-Spectrum β-Lactamases in Brazil: A Systematic Review.Microb Drug Resist. 2016 Jun;22(4):301-11. doi: 10.1089/mdr.2015.0180. Epub 2015 Dec 15. Microb Drug Resist. 2016. PMID: 26669767 Review.
-
The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: the complexity of clones and plasmids.Curr Opin Microbiol. 2019 Oct;51:51-56. doi: 10.1016/j.mib.2019.06.004. Epub 2019 Jul 17. Curr Opin Microbiol. 2019. PMID: 31325664 Review.
Cited by
-
Effect of rifampicin combination-regimens against multi-drug resistant strains in North India.Bioinformation. 2022 May 31;18(5):482-487. doi: 10.6026/97320630018482. eCollection 2022. Bioinformation. 2022. PMID: 36945223 Free PMC article.
-
Gold Nanoparticle-Based Resuscitation of Cefoxitin against Clinical Pathogens: A Nano-Antibiotic Strategy to Overcome Resistance.Nanomaterials (Basel). 2022 Oct 18;12(20):3643. doi: 10.3390/nano12203643. Nanomaterials (Basel). 2022. PMID: 36296833 Free PMC article.
-
Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Chickens and Humans in Egypt.Biology (Basel). 2021 Apr 26;10(5):373. doi: 10.3390/biology10050373. Biology (Basel). 2021. PMID: 33926062 Free PMC article.
-
Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance.Int J Mol Sci. 2019 May 18;20(10):2468. doi: 10.3390/ijms20102468. Int J Mol Sci. 2019. PMID: 31109079 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials